The hope was that once we have oral agents, theyre going to be less expensive than the injectable, because some of the justification for the higher cost of the injectable was the mode of delivery, the pens, says Rozalina McCoy, an endocrinologist and internist at the University of Maryland School of Medicine.* Even though Im not surprised, I am disappointed that the oral treatment, which doesnt have that higher cost, is going to be a [similar] price for patients. McCoy is also concerned that the relative ease of accessing the pills may increase their off-label use among people who do not have obesity
Im so happy that its finally in store because Im someone who likes to go in person and swatch and see how a product is
A Global Review on Short Peptides: Frontiers and Perspectives
Na strzykawce U-100: 5 kresek (jednostek / 0.05 ml) = 250 mcg (Standardowa dawka badawcza)
But medications leading to so much weight loss may be needed for people with severe obesity (a BMI of 35 or more) or the 10% of patients who dont respond to GLP-1 medications and need something more powerful, Azar said
